Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Cost-effectiveness of Anti-adhesion Treatment With HYALOBARRIER® GEL ENDO Versus no Gel Following the Removal by Hysteroscopy of Endometrial Polyps, Fibroids With Uterine Cavity Deformation, Uterine Septa, Intrauterine Adhesions or Retained Products of Conception for Improving Reproductive Outcome in Women Wishing to Become Pregnant: a Multi-centre, Parallel Group, Superiority, Double-blind, Randomized Controlled Trial

NCT03880435 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT03880435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03880435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Cost-effectiveness of Anti-adhesion Treatment With HYALOBARRIER® GEL ENDO Versus no Gel Following the Removal by Hysteroscopy of Endometrial Polyps, Fibroids With Uterine Cavity Deformation, Uterine Septa, Intrauterine Adhesions or Retained Products of Conception for Improving Reproductive Outcome in Women Wishing to Become Pregnant: a Multi-centre, Parallel Group, Superiority, Double-blind, Randomized Controlled Trial
Lead sponsor
University Hospital, Ghent
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2019
Completion date
May 31, 2025
Enrollment
419 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhesion, hysteroscopy, infertility, myoma;uterus, polyp uterus, retained products of conception, uterine septum